Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorvardur R Halfdanarson

Showing results (181-190 of 213) with videos related to

Pageof 22
Sort By:
Cancers|May 25, 2024
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal AdenocarcinomaAakash Desai, Alexander H Xiao, Daheui Choi, et al.
JACC. Advances|April 23, 2026
The Clinical Impact of Patent Foramen Ovale in Patients With Carcinoid Heart DiseaseIsabel G Scalia, Omar H Ibrahim, Fatmaelzahraa E Abdelfattah, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE studyNicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
Journal of Neuroendocrinology|June 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart diseaseMarkus Ammann, Hallbera Gudmundsdottir, Vanja Podrascanin, et al.
CA: a Cancer Journal for Clinicians|April 29, 2024
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumorsAman Chauhan, Kelley Chan, Thorvardur R Halfdanarson, et al.
Pancreas|July 18, 2020
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine TumorsThorvardur R Halfdanarson, Jonathan R Strosberg, Laura Tang, et al.
Pancreas|December 20, 2019
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine TumorsJames R Howe, Nipun B Merchant, Claudius Conrad, et al.
Gastro Hep Advances|August 12, 2024
Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine TumorsShounak Majumder, Thorvardur R Halfdanarson, Calise K Berger, et al.
Advanced Biology|March 28, 2022
Understanding Suboptimal Response to Immune Checkpoint InhibitorsMojun Zhu, Henan Zhang, Katrina S Pedersen, et al.
Frontiers in Oncology|May 28, 2021
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9Roman O Kowalchuk, Scott C Lester, Rondell P Graham, et al.
Pageof 22

Showing results (181-190 of 213) with videos related to

Sort By:
Pageof 22
Cancers|May 25, 2024
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal AdenocarcinomaAakash Desai, Alexander H Xiao, Daheui Choi, et al.
JACC. Advances|April 23, 2026
The Clinical Impact of Patent Foramen Ovale in Patients With Carcinoid Heart DiseaseIsabel G Scalia, Omar H Ibrahim, Fatmaelzahraa E Abdelfattah, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE studyNicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
Journal of Neuroendocrinology|June 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart diseaseMarkus Ammann, Hallbera Gudmundsdottir, Vanja Podrascanin, et al.
CA: a Cancer Journal for Clinicians|April 29, 2024
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumorsAman Chauhan, Kelley Chan, Thorvardur R Halfdanarson, et al.
Pancreas|July 18, 2020
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine TumorsThorvardur R Halfdanarson, Jonathan R Strosberg, Laura Tang, et al.
Pancreas|December 20, 2019
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine TumorsJames R Howe, Nipun B Merchant, Claudius Conrad, et al.
Gastro Hep Advances|August 12, 2024
Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine TumorsShounak Majumder, Thorvardur R Halfdanarson, Calise K Berger, et al.
Advanced Biology|March 28, 2022
Understanding Suboptimal Response to Immune Checkpoint InhibitorsMojun Zhu, Henan Zhang, Katrina S Pedersen, et al.
Frontiers in Oncology|May 28, 2021
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9Roman O Kowalchuk, Scott C Lester, Rondell P Graham, et al.
Pageof 22